Editorial: Posttransplant prophylaxis strategies for hepatitis B

American Journal of Transplantation

Volumn 10, Issue 8, 2010, Pages 1721-1722

  Gane, E ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; EMTRICITABINE; ENTECAVIR; HEPATITIS B ANTIBODY; LAMIVUDINE; NUCLEOSIDE; TENOFOVIR; VIRUS DNA; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MEGADOSE; EDITORIAL; HEPATITIS B; HUMAN; LOW DRUG DOSE; MONOTHERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; LIVER TRANSPLANTATION; NOTE;

HEPATITIS B; HUMANS; IMMUNOGLOBULINS; LAMIVUDINE; LIVER TRANSPLANTATION; RECURRENCE;

EID: 77954929025     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03193.x     Document Type: Editorial

References (10)

1. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993 329 : 1842 1847.
2. Marzano A, Salizzoni M, Dbernardi-Venon W et al. Prevention of hepatitis B recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001 34 : 903 910.
3. Gane EJ, Angus PW, Strasser S et al Australasian Liver Transplant Study Group. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007 132 : 931 937.
4. Markowitz J, Martin P, Conrad JA et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination of lamivudine plus hepatitis B immunoglobulin. Hepatology 1998 28 585 589.
5. Burbach G, Bienzle U, Neuhaus R et al. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of HBV reinfection after orthotopic liver transplantation. Transplantation 1997 63 : 478 480.
6. Levitsky J, Doucette K. Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009 9 : S116 S130.
7. Angus PW, Patterson SJ, Strasser SI, McCaughan GW, Gane E. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Hepatology 2008 48 : 1460 1466.
8. Liaw Y-F, Leung N, Kao J-H et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol Int 2008 2 : 263 283.
9. Teperman L, Spivey J, Poordad F et al. Emtricitabine/tenofovir combination +/- HBIG postorthotopic liver transplantation to prevent hepatitis B recurrence in patients with normal to moderate renal impairment. J Hepatol 2010 (in press).
10. Gane E, Strasser S, Angus P et al. A prospective study on the safety and efficacy of lamivudine and adefovir prophylaxis in HBsAg positive liver transplantation candidates. Hepatology 2007 46 : 479A.